Literature DB >> 12690279

Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination.

Yhu-Chering Huang1, Tzou-Yien Lin, Shu-Li Wu, Kou-Chien Tsao.   

Abstract

Five children, ages 3 to 6 years, developed visual hallucination and inappropriate behavior within 3 days of the onset of an influenza-like illness. Electroencephalographic examinations showed generalized slow waves in all five cases. Evidence of acute influenza A viral infection was documented in all five cases. Within 8 days all five children were discharged in stable condition. Influenza A-associated central nervous system dysfunction may be more common than previously recognized, and the prognosis is not necessarily poor.

Entities:  

Mesh:

Year:  2003        PMID: 12690279     DOI: 10.1097/01.inf.0000059763.79081.9a

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers.

Authors:  S S Jhee; M Yen; L Ereshefsky; M Leibowitz; M Schulte; B Kaeser; L Boak; A Patel; G Hoffmann; E P Prinssen; C R Rayner
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

2.  The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.

Authors:  William A Blumentals; Xue Song
Journal:  MedGenMed       Date:  2007-10-30

Review 3.  Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Authors:  Stephen Toovey; Craig Rayner; Eric Prinssen; Tom Chu; Barbara Donner; Bharat Thakrar; Regina Dutkowski; Gerhard Hoffmann; Alexander Breidenbach; Lothar Lindemann; Ellen Carey; Lauren Boak; Ronald Gieschke; Susan Sacks; Jonathan Solsky; Ian Small; David Reddy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  Influenza-associated neurological complications.

Authors:  Jenny P Tsai; Andrew J Baker
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

5.  Effects of vaccination and the new neuraminidase inhibitor, laninamivir, on influenza infection.

Authors:  Takuro Mizuno; Shigeru Mizuno; Tsugiyasu Kanda
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

6.  Neurologic aspects of influenza viruses.

Authors:  Larry E Davis; Fredrick Koster; Andrew Cawthon
Journal:  Handb Clin Neurol       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.